Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Clin Transl Oncol ; 2024 Jun 12.
Artigo em Inglês | MEDLINE | ID: mdl-38865035

RESUMO

PURPOSE: Peripherally inserted central venous catheters (PICC) in the onco-hematological patients may be associated with thrombosis or infections that may have short- to medium-term repercussions. MATERIAL AND METHODS: Single-centre retrospective analysis of a prospectively collected cohort. Primary objective was to establish the PICC-thrombosis and infections incidence. Secondary objectives were to analyze profile of patients suffering from these complications and variables associated with an increased likelihood of developing these events. RESULTS: 549 patients were recruited. 58.5% (n = 321) were oncology patients and 41.5% (n = 228) hematology patients. The incidence of PICC-associated thrombosis was 3.5% (n = 19). Thrombosis was associated with progression of the underlying malignant pathology in 10.6% (n = 2) of cases. No association was found between clinical variables analysed and development of thrombosis. Incidence of PICC-associated infections was 7.65% (n = 42). In the 30 days prior to PICC infection, 57.1% (n = 24) had a febrile syndrome of another focus, 73.8% (n = 11) had been hospitalized, 49.5% (n = 25) had a neutrophil count of 0-500 cells/mm3 and 47.6% (n = 20) had an episode of neutropenic fever. Variables significantly associated with the development of infection were hematological patients, high-flow PICC, 3-lm PICC or PICC insertion because of administration of vesicant therapy. CONCLUSIONS: Incidence of PICC-associated thrombosis is low and apparently less prognostically aggressive than other forms of thrombosis associated with cancer, without identify predictive factors. Infection was more prevalent and the identification of risk factors in our series could facilitate its prevention.

2.
Clin Transl Oncol ; 26(5): 1129-1138, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-37872422

RESUMO

PURPOSE: Currently, 15% of gynaecological and 9% of haematological malignancies are diagnosed before the age of 40. The increased survival rates of cancer patients who are candidates for gonadotoxic treatments, the delay in childbearing to older ages, and the optimization of in vitro fertilisation techniques have all contributed to an increased interest in fertility preservation (FP) treatments. This study reviews the experience of the Fertility Preservation Programme (FPP) of a tertiary public hospital with a multidisciplinary approach. METHODS: This retrospective study included all the available (FP) treatments, performed in patients of childbearing age between 2006 and 2022. RESULTS: 1556 patients were referred to the FPP: 332 oocyte vitrification cycles, 115 ovarian cortex cryopreservation with 11 orthotopic autotransplantations, 175 gonadotropin-releasing hormone (GnRH) agonist treatments, 109 fertility-sparing treatments for gynaecological cancer, and 576 sperm cryopreservation were performed. Malignancy was the main indication for FP (the main indications being breast cancer in women and haematological malignancies in men), although non-oncological pathologies, such as endometriosis and autoimmune diseases, have increased in recent years. Currently, the most widely used FP technique is oocyte vitrification, the increase of which has been associated with a decrease in the use of cortex CP and GnRH agonists. CONCLUSIONS: The increase in FP treatment reflects the implementation of reproductive counselling in oncology programmes. A multidisciplinary approach in a tertiary public hospital allows individualised FP treatment for each patient. In recent years, there has been a change in trend with the introduction of new indications for FP and a change in techniques due to their optimisation.

3.
J Fungi (Basel) ; 9(8)2023 Aug 13.
Artigo em Inglês | MEDLINE | ID: mdl-37623615

RESUMO

The present study aimed to describe the clinical, epidemiological and laboratory characteristics of invasive candidiasis by C. parapsilosis complex (CPC) in a Brazilian tertiary pediatric hospital during the COVID-19 pandemic. Clinical samples were processed in the BACT/ALERT® 3D system or on agar plates. Definitive identification was achieved by MALDI-TOF MS. Antifungal susceptibility was initially analyzed by the VITEK 2 system (AST-YS08 card) and confirmed by the CLSI protocol. Patient data were collected from the medical records using a structured questionnaire. CPC was recovered from 124 patients over an 18-month period, as follows: C. parapsilosis (83.87%), C. orthopsilosis (13.71%) and C. metapsilosis (2.42%). Antifungal resistance was not detected. The age of the patients with invasive CPC infections ranged from <1 to 18 years, and most of them came from oncology-related sectors, as these patients were more affected by C. parapsilosis. C. orthopsilosis infections were significantly more prevalent in patients from critical care units. Invasive infections caused by different pathogens occurred in 75 patients up to 30 days after the recovery of CPC isolates. Overall, 23 (18.55%) patients died within 30 days of CPC diagnosis. Catheter removal and antifungal therapy were important measures to prevent mortality. COVID-19 coinfection was only detected in one patient.

4.
BMC Cancer ; 23(1): 253, 2023 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-36927771

RESUMO

BACKGROUND: Difficulties in cancer services access increase the burden of disease and mortality in rural areas, and telehealth can be a useful tool to address these inequalities. OBJECTIVE: We aimed to describe the outcomes of patients in rural and urban areas with solid tumors managed by oncologists through telemedicine. METHODS: We conducted a retrospective cohort study of patients with solid tumors from March to December 2020. A total of 1270 subjects with solid tumors were included, 704 living in urban areas and 566 in rural areas. RESULTS: The most frequent tumors were breast (51.8%) and prostate (12.4%). The trend of telemedicine care was similar for both populations; in-person care was more frequent in the urban population. There were no differences in referral to the emergency room, need for hospitalization, and mortality for both groups. CONCLUSION: Telemedicine is a care modality that reduces barriers in the care of patients with solid tumors, evidencing similar outcomes regardless of living in rural or urban areas.


Assuntos
Neoplasias , Telemedicina , Masculino , Humanos , Estudos Retrospectivos , América Latina , Neoplasias/epidemiologia , Neoplasias/terapia , População Rural , Hospitais
5.
Mem. Inst. Oswaldo Cruz ; 117: e210383, 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1375925

RESUMO

BACKGROUND Chikungunya virus (CHIKV) is an arbovirus that can cause chronic and debilitating manifestations. The first autochthonous case in Rio de Janeiro state was diagnosed in 2015, and an outbreak was declared in 2016. OBJECTIVE The aim of this work was to evaluate CHIKV viral load in serum, plasma and urine in cancer patients to determine the best sample for diagnosis, as well as perform molecular characterisation and phylogenetic analysis of circulating strains. METHODS Paired serum, plasma and urine collected from 31 cancer patients were tested by real-time quantitative polymerase chain reaction (qPCR) and a segment of the CHIKV E1 gene was sequenced. FINDINGS We detected 11 CHIKV+ oncological patients. Paired samples analyses of nine patients showed a different pattern of detection. Also, a higher viral load in plasma (6.84 log10) and serum (6.07 log10) vs urine (3.76 log10) was found. Phylogenetic analysis and molecular characterisation revealed East/Central/Southern Africa (ECSA) genotype circulation and three amino acids substitutions (E1-K211T, E1-M269V, E1-T288I) in positive patients. MAIN CONCLUSION The results indicate the bioequivalence of serum and plasma for CHIKV diagnosis, with urine being an important complement. ECSA genotype was circulating among patients in the period of the 2016 outbreak with K211T, M269V and T288I substitution.

6.
Photodiagnosis Photodyn Ther ; 32: 101997, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32961326

RESUMO

Neutropenic ulcers are characterized by regular margins with a yellowish membrane, and are usually associated with severe pain and signs of inflammation due to opportunistic infections. Considering the immunosuppressed condition of these patients, local management of these lesions is a challenge. Antimicrobial photodynamic therapy (aPDT) is the association of light, which can be a low-power laser, with a photosensitizing agent and oxygen, whose synergy produces reactive oxygen species capable of reducing non-specific microbial contamination without causing side effects. The aim of this paper is to report a case of oral neutropenic ulcer treated with aPDT. A 50-year-old diabetic woman undergoing breast cancer treatment, presented with a malodorous malodorous and painful ulcer, which limited her basic oral functions. It was located in the maxillary alveolar ridge in the left first upper molar region and did not present bone involvement. Blood tests showed grade 2 of neutropenia. Thus, conservative treatment with aPDT technique was proposed. After one week, the lesion showed an improvement and pain had halved. The region was totally healed after three weeks. Local and non-invasive management of these lesions is of utmost importance for immunosuppressed patients, because it avoids systemic side effects and bacterial resistance resulting from overuse of antibiotics.


Assuntos
Infecções Bacterianas , Neoplasias da Mama , Fotoquimioterapia , Infecções Bacterianas/tratamento farmacológico , Neoplasias da Mama/complicações , Neoplasias da Mama/tratamento farmacológico , Feminino , Humanos , Pessoa de Meia-Idade , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Úlcera/tratamento farmacológico
7.
Rev. habanera cienc. méd ; 17(5): 800-812, set.-oct. 2018. tab
Artigo em Espanhol | LILACS, CUMED | ID: biblio-985626

RESUMO

Introducción: El sentido de la vida es lo que da significado y ayuda a encontrar un soporte interno a la existencia. Sin embargo, el padecimiento de una enfermedad oncológica pudiera conllevar su pérdida o afectación. Diversos logoterapeutas han intentado evaluar la percepción del sentido de la vida que experimenta el hombre mediante instrumentos de evaluación estandarizados. En Cuba no existe un instrumento que evalúe esta importante categoría psicológica. Objetivo: Determinar la fiabilidad y validez del instrumento Sentido de Vida en adultos con cáncer atendidos en el Instituto Nacional de Oncología y Radiobiología de La Habana, Cuba. Material y Métodos: La investigación consistió en el desarrollo de una tecnología para validar el Test Sentido de Vida mediante el análisis de Fiabilidad (a través de la Consistencia Interna) y el análisis de la Validez de contenido y de constructo. El Test Sentido de Vida, diseñado por Crumbaugh y Maholick y validado en la población española por Noblezas, fue sometido a un proceso de adaptación lingüística y cultural. En el diseño se contó con la participación de un grupo de cinco expertos psicólogos en la revisión del componente lingüístico, desde una perspectiva del contexto en que se aplicaría el instrumento. Resultados: Se obtuvo un α de Cronbach global de 0,853; se modificaron los ítems 6, 10,12 y 16 de los 20 reactivos que componen el test y a pesar de la concepción unidimensional del instrumento, se identificaron 5 componentes correlacionados entre sí. Conclusiones: Los resultados confirmaron la validez y confiabilidad del Test Sentido de Vida en los pacientes con cáncer estudiados(AU)


Introduction: The sense of life gives meaning and helps to find an internal support to existence. However, the suffering of an oncological disease could lead to its loss or affectation. Several logotherapists have tried to assess the perception of the sense of life experienced by the human being through standardized assessment instruments. In Cuba, there is no instrument that evaluates this important psychological category. Objective: To determine the reliability and validity of the Purpose in Life Test (PIL) in adults with cancer treated in the National Institute of Oncology and Radiobiology of Havana, Cuba. Material and Methods: The research consisted of the development of a technology aimed at validating the Purpose in Life Test (PIL) through the analysis of Internal Consistency Reliability and the analysis of the Content and Construct Validity. The Purpose in Life Test (PIL), which was designed by Crumbaugh and Maholick and validated in the Spanish population by the Nobility was submitted to a linguistic and cultural adaptation process. In the design, a group of five experts in Psychology participated in the review of the linguistic component from a context perspective in which the instrument would be applied. Results: Overall Cronbach's α was 0,853; items 6,10,12 and 16 of the 20 items that make up the test were modified and, despite the one-dimensional conception of the instrument, 5 correlated components were identified. Conclusions: The results confirmed the validity and reliability of the Purpose in Life Test in the patients with cancer studied(AU)


Assuntos
Humanos , Pacientes , Neoplasias , Vida , Estudo de Validação
8.
Clin Transl Oncol ; 19(1): 1-11, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27147252

RESUMO

Cancer is often complicated by venous thromboembolism (VTE), a common and potentially fatal complication associated with poor prognosis in these patients. An increased incidence of VTE is being observed due to the advanced age of cancer patients, the thrombogenic effect of novel drugs and advances in the diagnosis of related complications. In this review, we look at five different risk groups of cancer patients with an increased probability of developing VTE, including hospitalized patients undergoing chemotherapy, patients undergoing a surgical procedure, ambulatory patients undergoing chemotherapy, patients with a central venous access and patients receiving antiangiogenic drugs or anticoagulant therapy due to previous chronic diseases. The aim of this review is to summarize the most important clinical evidence reported to date on the suitability of primary thromboprophylaxis to cancer patients. Recommendations have drawn up for each group based on current evidence and guidelines to facilitate decision-making in clinical practice.


Assuntos
Anticoagulantes/uso terapêutico , Neoplasias/complicações , Tromboembolia Venosa/etiologia , Tromboembolia Venosa/prevenção & controle , Humanos , Prognóstico
10.
Dolor ; 21(57): 20-23, jul. 2011. tab, graf
Artigo em Espanhol | LILACS | ID: lil-695648

RESUMO

Objetivo: Averiguar las principales características de los pacientes pertenecientes a la Unidad de Alivio del Dolor y Cuidados Paliativos de Oncomed que fallecieron entre los años 2010 y 2011.Método: Se realizó un estudio retrospectivo, descriptivo y transversal de los pacientes pertenecientes a la Unidad que fallecieron durante los años 2010 y 2011. Se seleccionaron enfermos con patología oncológica terminal y que tuvieron como mínimo 1 atención médica. Se analizaron las variables de edad, sexo, patología oncológica, ciudad de residencia, tiempo de permanencia en la unidad y lugar de fallecimiento. Resultados: De los 832 pacientes, 46,2 por ciento fueron de sexo femenino y 53,8 por ciento masculino. Las edades fluctuaron entre los 3 y los 103 años, encontrándose el mayor número de enfermos entre los 40 y 80 años. Las patologías más comunes fueron cáncer de pulmón, próstata y gástrico, en el sexo masculino; y mama, pulmón y páncreas, en el sexo femenino. El mayor número de pacientes se localizó en la XIII Región. El tiempo promedio de sobrevida de los pacientes fue de 140 días, fluctuando entre 1 y 1.819 días. Un 73,4 por ciento de los pacientes falleció en el domicilio y un 26,6 por ciento hospitalizado. Conclusión: El estudio realizado resulta interesante ya que nos aporta conocimiento de las características de los pacientes que se atienden en nuestra unidad y eso nos ayuda a mejorar la planificación y organización de los servicios sanitarios, orientándolos a dar una mejor respuesta a las necesidades y demandas de nuestros enfermos.


Objective: To identify the main characteristics of patients belonging to the unit for Pain Relief and Palliative Care of Oncomed, who died in 2010 and 2011.Method: A retrospective, descriptive and transversal study has been done of the patients treated in the unit, who died during years 2010 and 2011. Patients with terminal cancer pathology have been selected, that have had at least one medical attention. The variables analyzed were age, sex, oncologic pathology, city of residence, length of stay in the unit and place of death. Results: Of the 832 patients, 46.2 percent were female and 53.8 percent male. The ages ranged from 3 to 103 years old, finding the largest number of patients between 40 and 80. The most common diseases were lung, prostate and gastric cancers in males and breast, lung and pancreas cancers in women. The largest number of patients was located in the XII Region. The median survival time of patients was 140 days, ranging between 1 and 1819 days. 73.4 percent of patients died at home and 26.6 percent at hospitals. Conclusion: The study shows interesting results, providing knowledge of the characteristics of our patients, helping us to improve the planning and organization of health services, focusing them to meet in a better way the requirements and demands of our patients.


Assuntos
Humanos , Masculino , Feminino , Pré-Escolar , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Adulto Jovem , Clínicas de Dor/estatística & dados numéricos , Neoplasias/mortalidade , Causas de Morte , Chile , Cuidados Paliativos/estatística & dados numéricos , Medição da Dor , Distribuição por Idade e Sexo , Estudos Retrospectivos , Estudos Transversais , Instituições Privadas de Saúde , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA